Role of microRNA-21 in diabetic kidney disease

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

In various kidney diseases including the most common cause of end stage kidney disease, diabetic nephropathy, identifying the molecular mechanisms responsible for kidney failure will greatly assist in defining new therapeutic targets in order to develop new treatments and therapies. The studies described in this proposal highlight the involvement of a novel class of small RNA molecules, and provide us with a novel approach to tackle this disease.

Funded Activity Details

Start Date: 01-01-2014

End Date: 01-01-2016

Funding Scheme: Project Grants

Funding Amount: $754,457.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Nephrology and Urology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

diabetic complications | diabetic nephropathy | extracellular matrix | renal fibrosis | transforming growth factor beta (TGF-beta)